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The title compound [MOM-SalB; systematic name: methyl
(2S,4aR,6aR,7R,9S,10aS,10bR)-2-(3-furyl)-9-methoxymeth-
oxy-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-
1H-benzo[f]isochromene-7-carboxylate], C23H30O8, is a deriv-
ative of the -opioid salvinorin A with enhanced potency,
selectivity, and duration of action. Superimposition of their
crystal structures reveals, surprisingly, that the terminal C and
O atoms of the MOM group overlap with the corresponding
atoms in salvinorin A, which are separated by an additional
bond. This counter-intuitive isosterism is possible because the
MOM ether adopts the ‘classic anomeric’ conformation
(gauche–gauche), tracing a helix around the planar acetate
of salvinorin A. This overlap is not seen in the recently
reported structure of the tetrahydropyranyl ether, which is
less potent. The classic anomeric conformation is strongly
favoured in alkoxymethyl ethers, but not in substituted
acetals, which may contribute to their reduced potency. This
structure may prove useful in evaluating models of the
activated -opioid receptor.
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et al. (2008); Prevatt-Smith et al. (2011). For in vivo pharma-
cology, see: Baker et al. (2009); Peet & Baker (2011); Wang et
al. (2008). For pharmacokinetics and PET imaging of the
ethoxymethyl ether, see: Hooker et al. (2009). For structure–
activity relationships of salvinorin A, see: Cunningham et al.
(2011). For crystal structures of related compounds, see:
Ortega et al. (1982); Prevatt-Smith et al. (2011); Tidgewell et al.
(2006). For solid-state and bioactive conformations of acetals,
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Data collection: APEX2 (Bruker, 2006); cell reﬁnement: SAINT
(Bruker, 2006); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: ORTEP-3 (Farrugia, 1997)
and pyMOL (DeLano, 2009); software used to prepare material for
publication: SHELXTL.
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Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: QM2086).
References
Anderson, J. E. (2000). J. Org. Chem. 65, 748–754.
Baker, L. E., Panos, J. J., Killinger, B. A., Peet, M. M., Bell, L. M., Haliw, L. A.
& Walker, S. L. (2009). Psychopharmacology (Berlin), 203, 203–211.
Be ´guin, C., Carlezon, W. A. Jr, Cohen, B. M., He, M., Lee, D. Y.-W., Richards,
M. R. & Liu-Chen, L.-Y. (2009). US Patent No. 7,629,475.
Be ´guin, C., Potuzak, J., Xu, W., Liu-Chen, L.-Y., Streicher, J. M., Groer, C. E.,
Bohn, L. M., Carlezon, W. A. Jr & Cohen, B. M. (2012). Bioorg. Med. Chem.
Lett. 22, 1023–1026.
Brameld, K. A., Kuhn, B., Reuter, D. C. & Stahl, M. (2008). J. Chem. Inf.
Model. 48, 1–24.
Bruker (2004). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2006). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin,
USA.
organic compounds
Acta Cryst. (2012). E68, o3225–o3226 doi:10.1107/S1600536812043449 Munro et al. o3225









O OCunningham, C. W., Rothman, R. B. & Prisinzano, T. E. (2011). Pharmacol.
Rev. 63, 316–347.
DeLano, W. L. (2009). pyMOL. DeLano Scientiﬁc LLC, San Carlos,
California, USA.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
Hooker, J. M., Munro, T. A., Be ´guin, C., Alexoff, D., Shea, C., Xu, Y. & Cohen,
B. M. (2009). Neuropharmacology, 57, 386–391.
Munro, T. A., Duncan, K. K., Xu, W., Wang, Y., Liu-Chen, L.-Y., Carlezon,
W. A. Jr, Cohen, B. M. & Be ´guin, C. (2008). Bioorg. Med. Chem. 16, 1279–
1286.
Ortega, A., Blount, J. F. & Manchand, P. S. (1982). J. Chem. Soc. Perkin Trans.
1, pp. 2505–2508.
Peet, M. M. & Baker, L. E. (2011). Behav. Pharmacol. 22, 450–457.
Prevatt-Smith, K. M., Lovell, K. M., Simpson, D. S., Day, V. W., Douglas, J. T.,
Bosch, P., Dersch, C. M., Rothman, R. B., Kivell, B. & Prisinzano, T. E.
(2011). MedChemComm, 2, 1217–1222.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122.
Tidgewell, K., Harding, W. W., Lozama, A., Cobb, H., Shah, K., Kannan, P.,
Dersch, C. M., Parrish, D., Deschamps, J. R., Rothman, R. B. & Prisinzano,
T. E. (2006). J. Nat. Prod. 69, 914–918.
Wang, Y., Chen, Y., Xu, W., Lee, D. Y., Ma, Z., Rawls, S. M., Cowan, A. & Liu-
Chen, L. Y. (2008). J. Pharmacol. Exp. Ther. 324, 1073–1083.
organic compounds
o3226 Munro et al.  C23H30O8 Acta Cryst. (2012). E68, o3225–o3226supplementary materials
sup-1 Acta Cryst. (2012). E68, o3225–o3226    
supplementary materials
Acta Cryst. (2012). E68, o3225–o3226    [doi:10.1107/S1600536812043449]
Salvinorin B methoxymethyl ether
Thomas A. Munro, Douglas M. Ho and Bruce M. Cohen
Comment 
Salvinorin B methoxymethyl ether (1) is among the most potent and selective κ (kappa) opioids known, with 
subnanomolar affinity and potency (Wang et al., 2008). A semisynthetic derivative of the naturally occurring κ opioid 
salvinorin A (2), (1) was the first derivative reported to be more potent than (2) in vitro, and also showed greater potency 
and duration of action in mice (Wang et al., 2008). The extreme potency of (1) has been confirmed both in vitro (Munro 
et al., 2008, Prevatt-Smith et al., 2011) and in rats (Baker et al., 2009, Peet & Baker, 2011). The name MOM-SalB is 
widely used; the incorrect name `2-methoxymethylsalvinorin B′, implying that the substituent is directly attached to C2, 
should be avoided.
In Figure 1, the structures of (1) and (2) have been drawn to emphasize their similarity, with O2, C21 and O3 
superimposable. The terminal methyl group C22 is attached to O3 in (1) but C21 in (2), and might be expected to interact 
with different regions of the receptor. Extensive research has been done into the structure-activity relationships of (2), 
especially the role of the C2 acetate. The deacetyl analogue salvinorin B is at least 60-fold less potent than (2). Deoxy-
genation or demethylation of the acetate causes smaller reductions in potency (Cunningham et al., 2011). This suggests 
that the two extremities of the acetate (O3 and C22) engage in separate, synergistic interactions with the binding pocket 
(Munro et al., 2008). The structure-activity relationships of (1) have also been explored. Potency is dramatically reduced 
by replacement of O3 with sulfur or carbon (Munro et al., 2008); this similarity to (2) is consistent with the proposed 
common binding pose. The ethoxymethyl ether (3) appears to be even more potent and selective than (1), both in vitro 
(Munro et al., 2008, Prevatt-Smith et al., 2011) and in vivo (Baker et al., 2009, Peet & Baker, 2011). Similarly, 12-epi-(3) 
reportedly exhibits higher affinity than 12-epi-(1) (Béguin et al., 2012). Further extension or branching of the terminal 
alkyl chain reduces affinity (Munro et al., 2008). Thus, the ethoxymethyl substituent appears to confer optimal affinity 
and potency. Like (1), (3) is also metabolized more slowly than (2) (Hooker et al., 2009). Based on the above hypothesis 
that the C22 methyl groups in (1) and (2) address different regions of the binding pocket, ethoxyethyl ether (4) was 
designed in that hope that it would interact with both of these regions, maximizing affinity. However, upon testing, (4) 
proved to have much lower affinity and potency than (3) (Munro et al., 2008, Prevatt-Smith et al., 2011). Indeed, all 
derivatives tested to date featuring substituted acetals, such as (5), exhibit reduced affinity and potency (Munro et al., 
2008, Prevatt-Smith et al., 2011). These surprising and disappointing results cast doubt on the proposed binding model. 
We therefore determined the structure of (1) by single-crystal X-ray diffraction to obtain conformational information 
(Figure 2).
Other than the disordered furan ring, the neoclerodane scaffold is almost perfectly superimposable (r.m.s. < 0.1 Å) upon 
that of (2), as expected (Ortega et al., 1982). However, the resulting relationship between the acetate and the MOM ether 
was unexpected. Both O3 and C22 in (1) overlap with their counterparts in (2), being separated by just 0.9 Å (O3) and 
1.2 Å (C22) – less than their atomic radii. The overlapping van der Waals surfaces of O3 and C22 are shown in Figure 3. 
This result was surprising, given the different point of attachment of C22 in these two compounds (Figure 1). This supplementary materials
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counterintuitive result occurs because both bonds to the acetal carbon C21 in (1) are gauche (torsion angles: 69.8° (O2—
C22) and 76.5° (C2—O3)), allowing the ether to trace a part helix around the planar acetate in (2). This is known as the 
`classic anomeric′ conformation (Anderson, 2000, Brameld et al., 2008). Generally, solid-state conformations coincide 
closely with the bioactive conformation of the protein-bound ligand (Brameld et al., 2008). This is because both solid-
state and bound conformations tend toward the free energy minimum. The similarity is greatest in high-affinity ligands, 
since any change in conformation during binding requires energy, and this `energetic penalty′ reduces affinity (Brameld et 
al., 2008). As discussed above, structure-activity studies indicate that O3 and C22 contribute substantially to binding of 
both (2) and (1). The near-superimposability of these atoms in the crystal structures of these two high-affinity ligands 
suggests that they may represent similar bioactive conformations. Alkoxymethyl ethers invariably adopt the classic 
anomeric conformation, due to strong anomeric interactions involving both O atoms (Anderson, 2000, Brameld et al., 
2008). Interestingly, however, substitution of the acetal carbon introduces steric interactions which greatly reduce this 
preference. With a methyl substituent, as in (4), the classic anomeric conformation predominates, but is not exclusive. 
With larger substituents this conformation is strongly disfavoured, and rarely occurs (Anderson, 2000). If the classic 
anomeric conformation seen in (1) is optimal for binding, acetal substitution would therefore be expected to reduce 
affinity by this conformational influence, even if the substituents do not themselves interact unfavourably with the 
receptor. This may contribute to the dramatic reductions in affinity and potency seen even with small acetal substituents 
(Munro et al., 2008, Prevatt-Smith et al., 2011).
The recently reported crystal structure of the tetrahydropyranyl (THP) ether (5) illustrates this point (Prevatt-Smith et 
al., 2011). The cyclic acetal does not adopt the classic anomeric conformation, and superimposition on (2) gives much 
poorer overlap than seen with (1) (Figure 4). Acetal oxygen O3 is separated from its counterpart in (2) by 2.5 Å, and is 
instead almost coincident with C22 (<0.2 Å). Furthermore, the THP ring is disordered, consisting of a mixture of two 
interconvertible chair conformations. Thus, the THP ether exhibits weaker conformational preferences than the MOM 
ether, and much poorer overlap with (2). This may partly account for its lower potency. Our results suggest a possible 
conformational basis for the high binding affinity of salvinorin B alkoxymethyl ethers such as (1) and (3), and for the 
reduced affinity of substituted acetal derivatives such as (4) and (5). As a structurally atypical and extremely potent 
agonist, the structure of (1) reported here may prove useful in modelling the activation of the κ opioid receptor.
Experimental 
Compound (1) was prepared as described previously, by treatment of salvinorin B with CH3OCH2Cl and i-Pr2NEt in 
anhydrous CH2Cl2, and purified by flash chromatography on silica gel (Béguin et al., 2009). Amended characterization 
data have been reported elsewhere (Munro et al., 2008). Dissolution of 200 mg in minimal boiling methanol (~3 ml) and 
slow cooling gave colourless needles, mp 165–167 °C (438–440 K).
Refinement 
The 3-furyl substituent was treated with a two-site disorder model consisting of [O8, C13, C14, C15, C16] and [O8*, 
C13*, C14*, C15*, C16*] with refined site occupancy factors of 0.66 (2) and 0.34 (2), respectively. These ten atoms 
were included in the least-squares refinement with rigid bond, similar Uij, common plane and 1,2-distance restraints. All 
H atoms were allowed to ride on their respective C atoms with C—H distances constrained to the SHELXTL (Sheldrick, 
2008) default values for the specified functional groups at 193 K, i.e., 0.95, 0.98, 0.99 and 1.00 Å for the olefic, methyl, 
methylene and methine H atoms, respectively. The Uiso(H) values were set at 1.5Ueq(C) for the methyl H atoms and 
1.2Ueq(C) for all others. The Flack parameter obtained [x = 0.2 (7)] was inconclusive. The absolute stereochemistry of 
salvinorin B has been established via the p-bromobenzoate (Tidgewell et al., 2006).supplementary materials
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Computing details 
Data collection: APEX2 (Bruker, 2006); cell refinement: SAINT (Bruker, 2006); data reduction: SAINT (Bruker, 2006); 
program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL 
(Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997) and pyMOL (DeLano, 2009); software used to prepare 
material for publication: SHELXTL (Sheldrick, 2008).
Figure 1
Structures of compounds discussed. 
Figure 2
Crystal structure of (1) with 50% probability thermal displacement ellipsoids. Atom numbering follows the crystal 
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Figure 3
Superimposed structures of (1) in blue and (2) in black (CSD code BUJJIZ, Ortega et al., 1982). Spheres represent the 
van der Waals surfaces of O3 and C22, connected by dotted yellow lines (Cross-eyed stereoview). supplementary materials
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Figure 4
Superimposed structures of (2) in black with (5) in blue (major component) and purple (minor component)(CCDC 








Hall symbol: C 2y
a = 27.8848 (7) Å
b = 6.2415 (2) Å
c = 12.8212 (3) Å
β = 107.351 (1)°
V = 2129.9 (1) Å3
Z = 4
F(000) = 928
Dx = 1.355 Mg m−3supplementary materials
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Melting point = 438–440 K
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 9071 reflections
θ = 3.0–29.5°
µ = 0.10 mm−1
T = 193 K
Needle, colourless
0.25 × 0.13 × 0.07 mm
Data collection 
Bruker APEXII CCD 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
Detector resolution: 836.6 pixels mm-1
ω scans, 2580 0.5° rotations
Absorption correction: multi-scan 
(SADABS; Bruker, 2004)
Tmin = 0.975, Tmax = 0.993
27784 measured reflections
6195 independent reflections
5296 reflections with I > 2σ(I)
Rint = 0.033













Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map




2) + (0.062P)2 + 0.2734P] 




Δρmax = 0.28 e Å−3
Δρmin = −0.16 e Å−3
Special details 
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is 
used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based 
on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyz U iso*/Ueq Occ. (<1)
O1 0.34600 (4) 1.0459 (2) 0.20598 (9) 0.0363 (3)
O2 0.37399 (4) 1.1271 (2) 0.02768 (10) 0.0382 (3)
O3 0.28986 (5) 1.1470 (3) −0.07126 (12) 0.0533 (3)
O4 0.50180 (4) 0.3453 (2) 0.13791 (9) 0.0347 (2)
O5 0.53410 (4) 0.6752 (2) 0.15051 (11) 0.0434 (3)
O6 0.31648 (4) 0.4502 (3) 0.48120 (9) 0.0436 (3)
O7 0.39036 (5) 0.3347 (3) 0.57679 (9) 0.0458 (3)
O8 0.1529 (2) 0.3841 (16) 0.3150 (5) 0.0598 (16) 0.66 (2)
O8* 0.1624 (5) 0.306 (3) 0.3130 (11) 0.065 (3) 0.34 (2)
C1 0.36787 (5) 0.9006 (2) 0.17700 (11) 0.0249 (3)
C2 0.38017 (5) 0.9135 (3) 0.06823 (11) 0.0283 (3)
H2 0.3558 0.8201 0.0142 0.034*
C3 0.43320 (5) 0.8377 (3) 0.07636 (12) 0.0315 (3)
H3A 0.4360 0.8163 0.0019 0.038*
H3B 0.4576 0.9499 0.1126 0.038*
C4 0.44644 (5) 0.6293 (3) 0.14044 (11) 0.0257 (3)supplementary materials
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H4 0.4222 0.5171 0.1007 0.031*
C5 0.44100 (5) 0.6503 (2) 0.25776 (11) 0.0228 (2)
C6 0.45549 (5) 0.4362 (3) 0.31852 (12) 0.0267 (3)
H6A 0.4396 0.3176 0.2690 0.032*
H6B 0.4924 0.4176 0.3379 0.032*
C7 0.43961 (5) 0.4217 (3) 0.42203 (11) 0.0274 (3)
H7A 0.4498 0.2813 0.4576 0.033*
H7B 0.4565 0.5355 0.4738 0.033*
C8 0.38318 (5) 0.4474 (2) 0.39397 (11) 0.0244 (3)
H8 0.3678 0.3340 0.3391 0.029*
C9 0.36365 (5) 0.6644 (2) 0.34072 (11) 0.0237 (2)
C10 0.38330 (5) 0.6924 (2) 0.23975 (11) 0.0223 (2)
H10 0.3658 0.5780 0.1877 0.027*
C11 0.30621 (5) 0.6350 (3) 0.30016 (11) 0.0291 (3)
H11A 0.2906 0.7691 0.2645 0.035*
H11B 0.2980 0.5199 0.2445 0.035*
C12 0.28354 (5) 0.5783 (3) 0.39194 (12) 0.0320 (3)
H12 0.2766 0.7162 0.4245 0.038* 0.66 (2)
H12* 0.2744 0.7138 0.4231 0.038* 0.34 (2)
C13 0.2346 (2) 0.4602 (14) 0.3521 (11) 0.0399 (14) 0.66 (2)
C14 0.2245 (3) 0.2544 (13) 0.3026 (9) 0.0608 (16) 0.66 (2)
H14 0.2486 0.1629 0.2865 0.073* 0.66 (2)
C15 0.1763 (4) 0.2117 (11) 0.2826 (5) 0.0577 (16) 0.66 (2)
H15 0.1602 0.0830 0.2510 0.069* 0.66 (2)
C16 0.1899 (2) 0.5337 (15) 0.3570 (8) 0.0508 (17) 0.66 (2)
H16 0.1847 0.6694 0.3853 0.061* 0.66 (2)
C13* 0.2374 (3) 0.442 (2) 0.351 (2) 0.032 (2) 0.34 (2)
C14* 0.2354 (5) 0.241 (2) 0.2978 (16) 0.044 (2) 0.34 (2)
H14* 0.2634 0.1718 0.2848 0.052* 0.34 (2)
C15* 0.1891 (5) 0.165 (2) 0.2686 (15) 0.062 (3) 0.34 (2)
H15* 0.1769 0.0408 0.2264 0.075* 0.34 (2)
C16* 0.1910 (4) 0.481 (3) 0.3591 (14) 0.042 (2) 0.34 (2)
H16* 0.1802 0.6040 0.3898 0.051* 0.34 (2)
C17 0.36481 (6) 0.4082 (3) 0.49147 (12) 0.0321 (3)
C18 0.49892 (5) 0.5576 (3) 0.14339 (12) 0.0295 (3)
C19 0.47495 (5) 0.8301 (3) 0.32085 (12) 0.0293 (3)
H19A 0.5088 0.8135 0.3138 0.044*
H19B 0.4766 0.8225 0.3982 0.044*
H19C 0.4612 0.9692 0.2909 0.044*
C20 0.37823 (6) 0.8467 (3) 0.42559 (12) 0.0314 (3)
H20A 0.3662 0.8125 0.4881 0.047*
H20B 0.3629 0.9810 0.3921 0.047*
H20C 0.4149 0.8623 0.4505 0.047*
C21 0.33854 (7) 1.1533 (4) −0.07497 (15) 0.0486 (5)
H21A 0.3445 1.2925 −0.1060 0.058*
H21B 0.3433 1.0389 −0.1244 0.058*
C22 0.27678 (9) 1.3292 (5) −0.0192 (2) 0.0654 (6)
H22A 0.2403 1.3332 −0.0332 0.098*
H22B 0.2877 1.4595 −0.0482 0.098*supplementary materials
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H22C 0.2933 1.3206 0.0597 0.098*
C23 0.55100 (6) 0.2564 (3) 0.14724 (16) 0.0407 (4)
H23A 0.5492 0.0996 0.1474 0.061*
H23B 0.5751 0.3056 0.2155 0.061*
H23C 0.5620 0.3039 0.0851 0.061*
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O1 0.0463 (6) 0.0288 (5) 0.0338 (6) 0.0112 (5) 0.0120 (5) 0.0024 (4)
O2 0.0313 (5) 0.0392 (6) 0.0420 (6) 0.0014 (5) 0.0073 (4) 0.0178 (5)
O3 0.0365 (6) 0.0615 (9) 0.0539 (8) 0.0058 (6) 0.0015 (5) −0.0023 (7)
O4 0.0311 (5) 0.0329 (5) 0.0440 (6) 0.0031 (4) 0.0170 (5) −0.0081 (5)
O5 0.0319 (5) 0.0406 (7) 0.0629 (8) −0.0012 (5) 0.0221 (5) 0.0062 (6)
O6 0.0355 (6) 0.0683 (8) 0.0309 (6) 0.0052 (6) 0.0160 (5) 0.0144 (6)
O7 0.0433 (6) 0.0649 (8) 0.0291 (6) 0.0023 (6) 0.0105 (5) 0.0140 (6)
O8 0.0397 (17) 0.096 (4) 0.0512 (16) −0.019 (2) 0.0254 (14) −0.016 (2)
O8* 0.047 (4) 0.086 (7) 0.072 (5) −0.019 (4) 0.032 (3) 0.007 (4)
C1 0.0239 (6) 0.0249 (6) 0.0237 (6) −0.0013 (5) 0.0039 (5) −0.0001 (5)
C2 0.0283 (6) 0.0299 (7) 0.0266 (6) −0.0006 (6) 0.0081 (5) 0.0056 (6)
C3 0.0312 (7) 0.0364 (7) 0.0297 (7) 0.0035 (6) 0.0135 (6) 0.0075 (6)
C4 0.0252 (6) 0.0288 (7) 0.0250 (6) −0.0006 (5) 0.0103 (5) 0.0000 (5)
C5 0.0239 (6) 0.0211 (6) 0.0239 (6) −0.0001 (5) 0.0077 (5) 0.0000 (5)
C6 0.0291 (7) 0.0223 (6) 0.0301 (7) 0.0026 (5) 0.0109 (5) 0.0021 (5)
C7 0.0289 (6) 0.0265 (6) 0.0269 (6) 0.0026 (5) 0.0082 (5) 0.0051 (5)
C8 0.0284 (6) 0.0227 (6) 0.0228 (6) −0.0021 (5) 0.0086 (5) −0.0002 (5)
C9 0.0257 (6) 0.0239 (6) 0.0227 (6) 0.0010 (5) 0.0094 (5) −0.0004 (5)
C10 0.0247 (6) 0.0215 (6) 0.0213 (6) −0.0004 (5) 0.0078 (5) −0.0006 (5)
C11 0.0267 (6) 0.0371 (7) 0.0254 (7) 0.0017 (6) 0.0107 (5) 0.0028 (6)
C12 0.0308 (7) 0.0376 (8) 0.0306 (7) 0.0020 (6) 0.0137 (6) 0.0021 (6)
C13 0.045 (3) 0.040 (2) 0.037 (3) −0.006 (2) 0.015 (3) 0.007 (2)
C14 0.060 (3) 0.046 (2) 0.083 (3) 0.001 (3) 0.033 (3) 0.001 (2)
C15 0.064 (4) 0.057 (3) 0.063 (2) −0.024 (3) 0.035 (2) −0.015 (2)
C16 0.043 (2) 0.071 (4) 0.042 (3) −0.007 (2) 0.0173 (18) −0.008 (3)
C13* 0.022 (3) 0.043 (5) 0.037 (5) 0.005 (3) 0.018 (3) 0.003 (4)
C14* 0.035 (3) 0.031 (3) 0.070 (4) −0.011 (3) 0.024 (3) −0.017 (3)
C15* 0.046 (5) 0.049 (4) 0.098 (6) −0.022 (4) 0.031 (4) −0.010 (4)
C16* 0.034 (4) 0.067 (5) 0.038 (4) 0.007 (3) 0.030 (3) 0.012 (4)
C17 0.0345 (7) 0.0362 (8) 0.0271 (7) −0.0030 (6) 0.0114 (6) 0.0015 (6)
C18 0.0281 (7) 0.0346 (7) 0.0285 (7) 0.0012 (6) 0.0126 (6) 0.0014 (6)
C19 0.0300 (7) 0.0259 (6) 0.0309 (7) −0.0046 (6) 0.0073 (5) −0.0023 (6)
C20 0.0402 (8) 0.0281 (7) 0.0273 (7) −0.0001 (6) 0.0121 (6) −0.0041 (6)
C21 0.0445 (9) 0.0660 (12) 0.0357 (9) 0.0152 (9) 0.0126 (7) 0.0210 (9)
C22 0.0532 (12) 0.0669 (14) 0.0752 (15) 0.0227 (11) 0.0176 (11) 0.0014 (13)
C23 0.0338 (8) 0.0450 (9) 0.0468 (10) 0.0088 (7) 0.0172 (7) −0.0058 (7)
Geometric parameters (Å, º) 
O1—C1 1.2112 (17) C9—C11 1.5404 (19)
O2—C21 1.400 (2) C9—C20 1.543 (2)supplementary materials
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O2—C2 1.4225 (18) C9—C10 1.5586 (17)
O3—C21 1.373 (2) C10—H10 1.0000
O3—C22 1.420 (3) C11—C12 1.5340 (19)
O4—C18 1.3305 (19) C11—H11A 0.9900
O4—C23 1.4513 (18) C11—H11B 0.9900
O5—C18 1.2067 (19) C12—C13* 1.500 (3)
O6—C17 1.3404 (18) C12—C13 1.501 (2)
O6—C12 1.4715 (19) C12—H12 1.0000
O7—C17 1.2040 (19) C12—H12* 1.0000
O8—C16 1.377 (3) C13—C16 1.346 (3)
O8—C15 1.385 (3) C13—C14 1.423 (3)
O8*—C16* 1.378 (3) C14—C15 1.320 (3)
O8*—C15* 1.380 (3) C14—H14 0.9500
C1—C10 1.5214 (18) C15—H15 0.9500
C1—C2 1.5344 (18) C16—H16 0.9500
C2—C3 1.5263 (19) C13*—C16* 1.349 (3)
C2—H2 1.0000 C13*—C14* 1.423 (3)
C3—C4 1.524 (2) C14*—C15* 1.320 (3)
C3—H3A 0.9900 C14*—H14* 0.9500
C3—H3B 0.9900 C15*—H15* 0.9500
C4—C18 1.5198 (19) C16*—H16* 0.9500
C4—C5 1.5617 (18) C19—H19A 0.9800
C4—H4 1.0000 C19—H19B 0.9800
C5—C19 1.5340 (19) C19—H19C 0.9800
C5—C6 1.5390 (19) C20—H20A 0.9800
C5—C10 1.5778 (17) C20—H20B 0.9800
C6—C7 1.5216 (19) C20—H20C 0.9800
C6—H6A 0.9900 C21—H21A 0.9900
C6—H6B 0.9900 C21—H21B 0.9900
C7—C8 1.5147 (19) C22—H22A 0.9800
C7—H7A 0.9900 C22—H22B 0.9800
C7—H7B 0.9900 C22—H22C 0.9800
C8—C17 1.5054 (18) C23—H23A 0.9800
C8—C9 1.5415 (19) C23—H23B 0.9800
C8—H8 1.0000 C23—H23C 0.9800
C21—O2—C2 115.33 (14) O6—C12—C13 106.9 (5)
C21—O3—C22 112.85 (17) O6—C12—C11 114.68 (11)
C18—O4—C23 116.56 (13) C13*—C12—C11 111.9 (9)
C17—O6—C12 123.97 (11) C13—C12—C11 113.2 (5)
C16—O8—C15 106.2 (4) O6—C12—H12 107.2
C16*—O8*—C15* 111.6 (8) C13—C12—H12 107.2
O1—C1—C10 124.47 (12) C11—C12—H12 107.2
O1—C1—C2 120.59 (12) O6—C12—H12* 108.8
C10—C1—C2 114.89 (11) C13*—C12—H12* 108.8
O2—C2—C3 108.95 (11) C11—C12—H12* 108.8
O2—C2—C1 110.23 (12) C16—C13—C14 105.5 (4)
C3—C2—C1 113.35 (11) C16—C13—C12 125.2 (5)
O2—C2—H2 108.1 C14—C13—C12 129.3 (6)supplementary materials
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C3—C2—H2 108.1 C15—C14—C13 108.8 (4)
C1—C2—H2 108.1 C15—C14—H14 125.6
C4—C3—C2 112.05 (11) C13—C14—H14 125.6
C4—C3—H3A 109.2 C14—C15—O8 109.2 (4)
C2—C3—H3A 109.2 C14—C15—H15 125.4
C4—C3—H3B 109.2 O8—C15—H15 125.4
C2—C3—H3B 109.2 C13—C16—O8 110.3 (4)
H3A—C3—H3B 107.9 C13—C16—H16 124.8
C18—C4—C3 109.94 (11) O8—C16—H16 124.8
C18—C4—C5 111.73 (11) C16*—C13*—C14* 107.1 (6)
C3—C4—C5 111.70 (11) C16*—C13*—C12 128.0 (8)
C18—C4—H4 107.8 C14*—C13*—C12 124.9 (8)
C3—C4—H4 107.8 C15*—C14*—C13* 110.3 (8)
C5—C4—H4 107.8 C15*—C14*—H14* 124.8
C19—C5—C6 109.92 (11) C13*—C14*—H14* 124.8
C19—C5—C4 110.34 (10) C14*—C15*—O8* 104.9 (9)
C6—C5—C4 109.16 (11) C14*—C15*—H15* 127.6
C19—C5—C10 113.43 (11) O8*—C15*—H15* 127.6
C6—C5—C10 108.71 (10) C13*—C16*—O8* 105.6 (7)
C4—C5—C10 105.12 (10) C13*—C16*—H16* 127.2
C7—C6—C5 113.11 (11) O8*—C16*—H16* 127.2
C7—C6—H6A 109.0 O7—C17—O6 117.96 (13)
C5—C6—H6A 109.0 O7—C17—C8 124.09 (14)
C7—C6—H6B 109.0 O6—C17—C8 117.89 (12)
C5—C6—H6B 109.0 O5—C18—O4 123.31 (13)
H6A—C6—H6B 107.8 O5—C18—C4 125.31 (14)
C8—C7—C6 109.78 (11) O4—C18—C4 111.38 (12)
C8—C7—H7A 109.7 C5—C19—H19A 109.5
C6—C7—H7A 109.7 C5—C19—H19B 109.5
C8—C7—H7B 109.7 H19A—C19—H19B 109.5
C6—C7—H7B 109.7 C5—C19—H19C 109.5
H7A—C7—H7B 108.2 H19A—C19—H19C 109.5
C17—C8—C7 111.86 (11) H19B—C19—H19C 109.5
C17—C8—C9 110.35 (11) C9—C20—H20A 109.5
C7—C8—C9 113.75 (11) C9—C20—H20B 109.5
C17—C8—H8 106.8 H20A—C20—H20B 109.5
C7—C8—H8 106.8 C9—C20—H20C 109.5
C9—C8—H8 106.8 H20A—C20—H20C 109.5
C11—C9—C8 103.83 (11) H20B—C20—H20C 109.5
C11—C9—C20 110.78 (11) O3—C21—O2 113.10 (14)
C8—C9—C20 110.59 (11) O3—C21—H21A 109.0
C11—C9—C10 108.70 (10) O2—C21—H21A 109.0
C8—C9—C10 107.52 (10) O3—C21—H21B 109.0
C20—C9—C10 114.80 (11) O2—C21—H21B 109.0
C1—C10—C9 114.89 (11) H21A—C21—H21B 107.8
C1—C10—C5 109.55 (10) O3—C22—H22A 109.5
C9—C10—C5 117.10 (10) O3—C22—H22B 109.5
C1—C10—H10 104.6 H22A—C22—H22B 109.5
C9—C10—H10 104.6 O3—C22—H22C 109.5supplementary materials
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C5—C10—H10 104.6 H22A—C22—H22C 109.5
C12—C11—C9 113.17 (11) H22B—C22—H22C 109.5
C12—C11—H11A 108.9 O4—C23—H23A 109.5
C9—C11—H11A 108.9 O4—C23—H23B 109.5
C12—C11—H11B 108.9 H23A—C23—H23B 109.5
C9—C11—H11B 108.9 O4—C23—H23C 109.5
H11A—C11—H11B 107.8 H23A—C23—H23C 109.5
O6—C12—C13* 103.5 (10) H23B—C23—H23C 109.5
C21—O2—C2—C3 114.88 (14) C20—C9—C11—C12 −60.11 (16)
C21—O2—C2—C1 −120.16 (14) C10—C9—C11—C12 172.88 (12)
O1—C1—C2—O2 14.32 (18) C17—O6—C12—C13* 130.8 (6)
C10—C1—C2—O2 −167.98 (11) C17—O6—C12—C13 134.9 (4)
O1—C1—C2—C3 136.74 (15) C17—O6—C12—C11 8.6 (2)
C10—C1—C2—C3 −45.56 (16) C9—C11—C12—O6 −32.17 (18)
O2—C2—C3—C4 168.32 (12) C9—C11—C12—C13* −149.7 (8)
C1—C2—C3—C4 45.19 (17) C9—C11—C12—C13 −155.2 (4)
C2—C3—C4—C18 178.41 (12) O6—C12—C13—C16 116.8 (10)
C2—C3—C4—C5 −56.95 (16) C11—C12—C13—C16 −115.9 (10)
C18—C4—C5—C19 65.23 (14) O6—C12—C13—C14 −63.2 (12)
C3—C4—C5—C19 −58.40 (14) C11—C12—C13—C14 64.0 (12)
C18—C4—C5—C6 −55.66 (14) C16—C13—C14—C15 −1.4 (9)
C3—C4—C5—C6 −179.29 (11) C12—C13—C14—C15 178.7 (12)
C18—C4—C5—C10 −172.13 (12) C13—C14—C15—O8 1.2 (9)
C3—C4—C5—C10 64.24 (13) C16—O8—C15—C14 −0.6 (8)
C19—C5—C6—C7 72.79 (14) C14—C13—C16—O8 1.0 (9)
C4—C5—C6—C7 −166.06 (11) C12—C13—C16—O8 −179.0 (11)
C10—C5—C6—C7 −51.90 (14) C15—O8—C16—C13 −0.3 (9)
C5—C6—C7—C8 59.29 (15) O6—C12—C13*—C16* 112 (2)
C6—C7—C8—C17 173.22 (12) C11—C12—C13*—C16* −123.9 (19)
C6—C7—C8—C9 −60.92 (15) O6—C12—C13*—C14* −67.1 (19)
C17—C8—C9—C11 −63.99 (13) C11—C12—C13*—C14* 57 (2)
C7—C8—C9—C11 169.34 (11) C16*—C13*—C14*—C15* 3.1 (17)
C17—C8—C9—C20 54.87 (14) C12—C13*—C14*—C15* −178 (2)
C7—C8—C9—C20 −71.79 (14) C13*—C14*—C15*—O8* −5.8 (16)
C17—C8—C9—C10 −179.08 (11) C16*—O8*—C15*—C14* 6.7 (16)
C7—C8—C9—C10 54.26 (14) C14*—C13*—C16*—O8* 1.1 (16)
O1—C1—C10—C9 6.55 (19) C12—C13*—C16*—O8* −178 (2)
C2—C1—C10—C9 −171.04 (11) C15*—O8*—C16*—C13* −4.9 (17)
O1—C1—C10—C5 −127.68 (14) C12—O6—C17—O7 167.27 (17)
C2—C1—C10—C5 54.72 (14) C12—O6—C17—C8 −15.2 (2)
C11—C9—C10—C1 68.63 (14) C7—C8—C17—O7 −10.3 (2)
C8—C9—C10—C1 −179.56 (11) C9—C8—C17—O7 −138.04 (17)
C20—C9—C10—C1 −56.05 (15) C7—C8—C17—O6 172.30 (14)
C11—C9—C10—C5 −160.70 (11) C9—C8—C17—O6 44.60 (18)
C8—C9—C10—C5 −48.89 (14) C23—O4—C18—O5 3.4 (2)
C20—C9—C10—C5 74.63 (15) C23—O4—C18—C4 −176.09 (12)
C19—C5—C10—C1 58.93 (13) C3—C4—C18—O5 36.7 (2)
C6—C5—C10—C1 −178.48 (11) C5—C4—C18—O5 −87.90 (17)supplementary materials
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C4—C5—C10—C1 −61.70 (13) C3—C4—C18—O4 −143.75 (13)
C19—C5—C10—C9 −74.18 (14) C5—C4—C18—O4 91.63 (15)
C6—C5—C10—C9 48.42 (15) C22—O3—C21—O2 69.8 (2)
C4—C5—C10—C9 165.19 (11) C2—O2—C21—O3 76.5 (2)
C8—C9—C11—C12 58.63 (15)